Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.6979
Delayed Data
As of 3:59pm ET
 +0.0284 / +4.24%
Today’s Change
0.49
Today|||52-Week Range
2.77
-47.13%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$97.0M

Company Description

Nabriva Therapeutics Plc is a biopharmaceutical company, which engages in the research, development and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

Contact Information

Nabriva Therapeutics Plc
25-28 North Wall Quay
Dublin Dublin 1
P:(531) 649-2000
Investor Relations:

Employees

Shareholders

Individual stakeholders8.03%
Other institutional6.94%
Mutual fund holders6.85%

Top Executives

There are no executives to display.